Authorized Representative Services

Revision of MedDO and IVDO

New requirements for product groups without an intended medical purpose and alignment with Regulation (EU) 2023/607 on medical devices and in vitro diagnostic medical devices.

The Federal Council of Switzerland has decided to amend the Medical Devices Ordinance (MedDO) in alignment with EU requirements (Implementing Regulation 2023/1194), for product groups without an intended medical purpose.

The amendments on EU-MDR 2017/745, regarding changes to transitional periods for certificates, and on EU-MDR 2017/745 and EU-IVDR 2017/746, regarding the elimination of the sell-off period, were also transposed to the MedDO and IvDO. The approved amendments to the MedDO and IvDO will become effective on 1st November 2023.

More details can be found in the Swissmedic publication.

Add Comment

* Required information
1000
Captcha Image
Powered by Commentics

Comments

No comments yet. Be the first!
  • UK Responsible Person

    6 Wilmslow Road, Rusholme, Manchester M14 5TP, UK

    +44 7898 375115

  • U.S. Agent

    Chicago
    IL 60630
    USA

    +1 (312) 975-1694

  • Cosmetics Responsible Person

    Schiffgraben 41
    30175 Hannover
    Germany

    +49 511 6262 8630

  • CH-REP

    Laurenzenvorstadt 61
    5000 Aarau
    Switzerland

  • Importer

    Limmerstraße 15
    30451 Hannover
    Germany

    +49 511 62 62 86 30

MDSS GmbH

Schiffgraben 41
30175 Hannover
Germany

Share

Stay informed